全球橫向流動化驗市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計橫向流動化驗市場將從 2025 年的 106.2 億美元成長到 2034 年的 184.7 億美元，2026 年至 2034 年的複合年成長率為 6.34%。

由於醫療機構整體快速診斷檢測的需求不斷成長，全球橫向流動化驗市場正迅速發展。橫向流動化驗無需複雜的檢查室設備即可提供快速可靠的結果，因此廣泛應用於就地檢驗。這些檢測通常用於檢測感染疾病、懷孕、心臟標記和藥物濫用。其易用性和成本效益使其在已開發國家和開發中國家的醫療體系中都廣受歡迎。

推動該市場擴張的因素有很多，包括感染疾病的蔓延和對疾病早期檢測日益成長的需求。新冠肺炎疫情顯著提高了人們對快速檢測技術的認知度和應用率，進一步加速了市場成長。此外，診斷技術的進步和對居家檢測解決方案需求的成長，也促使製造商開發出更精準、更易用的側向流動檢測設備。

隨著醫療系統持續優先考慮快速診斷和分散式檢查，橫向流動化驗市場預計將會擴張。研發投入的增加正在推動更靈敏、多參數解決方案的開發。隨著醫療服務提供者尋求更快、更便捷的診斷工具，橫向流動化驗將繼續在改善全球醫療保健成果方面發揮關鍵作用。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球橫向流動化驗市場：依產品分類

• 市場分析、洞察與預測
• 試劑盒和試劑
• 側向流讀取儀
• 數位/行動閱讀器
• 桌面閱讀器

第5章 全球橫向流動化驗市場：依應用分類

• 市場分析、洞察與預測
• 臨床試驗
• 傳染病檢查
• 心臟標記檢測
• 妊娠和不孕症檢查
• 膽固醇檢測/血脂譜檢測
• 藥物檢測
• 獸醫診斷
• 食品安全與環境檢測
• 藥物研發和品質檢測
• 其他

第6章 全球橫向流動化驗市場：依方法分類

• 市場分析、洞察與預測
• 夾心法
• 競爭性檢測
• 多重檢測分析

第7章 全球橫向流動化驗市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院和診所
• 診斷檢查室
• 居家照護
• 製藥和生物技術公司
• 其他

第8章 全球橫向流動化驗市場：依檢測類型分類

• 市場分析、洞察與預測
• 側向流動免疫檢測
• 核酸橫向流動化驗

第9章 全球橫向流動化驗市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott
  • Bio-Rad Laboratories Inc
  • Siemens Healthineers AG
  • BioMerieux
  • BD
  • Qiagen
  • QuidelOrtho Corporation
  • F. Hoffmann-La Roche
  • DH Life Sciences LLC
  • Quest Diagnostics
  • Qiagen NV

The Lateral Flow Assay Market size is expected to reach USD 18.47 Billion in 2034 from USD 10.62 Billion (2025) growing at a CAGR of 6.34% during 2026-2034.

The global lateral flow assay market has grown rapidly due to the increasing demand for rapid diagnostic tests across healthcare settings. Lateral flow assays are widely used for point-of-care testing because they provide quick, reliable results without requiring complex laboratory infrastructure. These tests are commonly used for detecting infectious diseases, pregnancy, cardiac markers, and drug abuse. Their ease of use and cost-effectiveness make them popular in both developed and developing healthcare systems.

Several factors are driving the expansion of this market, including the rising prevalence of infectious diseases and the growing need for early disease detection. The COVID-19 pandemic significantly increased awareness and adoption of rapid testing technologies, further accelerating market growth. Additionally, advancements in diagnostic technologies and the growing demand for home-based testing solutions are encouraging manufacturers to develop more accurate and user-friendly lateral flow devices.

In the future, the lateral flow assay market is expected to expand as healthcare systems continue to prioritize rapid diagnostics and decentralized testing. Increasing investments in research and development are leading to the development of more sensitive and multiplex testing solutions. As healthcare providers seek faster and more accessible diagnostic tools, lateral flow assays will continue to play a crucial role in improving global healthcare outcomes.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Kits & Reagents
• Lateral Flow Readers
• Digital/Mobile Readers
• Benchtop Readers

By Application

• Clinical Testing
• Infectious Diseases Testing
• Cardiac Marker Testing
• Pregnancy & Fertility Testing
• Cholesterol Testing/Lipid Profile Testing
• Drugs of Abuse Testing
• Veterinary Diagnostics
• Food Safety & Environment Testing
• Drug Development & Quality Testing
• Others

By Technique

• Sandwich Assays
• Competitive Assays
• Multiplex Detection Assays

By End Use

• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care
• Pharmaceutical & Biotechnology Companies
• Others

By Test

• Lateral Flow Immunoassay
• Nucleic Acid Lateral Flow Assay

COMPANIES PROFILED

• Abbott, BioRad Laboratories Inc, Siemens Healthineers AG, bioMrieux, BD, Qiagen, QuidelOrtho Corporation, F HoffmannLa Roche, DH Life Sciences LLC, Quest Diagnostics, Qiagen NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL LATERAL FLOW ASSAY MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Lateral Flow Readers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Digital/Mobile Readers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Benchtop Readers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LATERAL FLOW ASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Infectious Diseases Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Cardiac Marker Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pregnancy & Fertility Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Cholesterol Testing/Lipid Profile Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Drugs of Abuse Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Veterinary Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Food Safety & Environment Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Drug Development & Quality Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LATERAL FLOW ASSAY MARKET: BY TECHNIQUE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technique
• 6.2. Sandwich Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Competitive Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Multiplex Detection Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LATERAL FLOW ASSAY MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Home Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LATERAL FLOW ASSAY MARKET: BY TEST 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Test
• 8.2. Lateral Flow Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Nucleic Acid Lateral Flow Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL LATERAL FLOW ASSAY MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product
  • 9.2.2 By Application
  • 9.2.3 By Technique
  • 9.2.4 By End Use
  • 9.2.5 By Test
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product
  • 9.3.2 By Application
  • 9.3.3 By Technique
  • 9.3.4 By End Use
  • 9.3.5 By Test
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product
  • 9.4.2 By Application
  • 9.4.3 By Technique
  • 9.4.4 By End Use
  • 9.4.5 By Test
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product
  • 9.5.2 By Application
  • 9.5.3 By Technique
  • 9.5.4 By End Use
  • 9.5.5 By Test
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product
  • 9.6.2 By Application
  • 9.6.3 By Technique
  • 9.6.4 By End Use
  • 9.6.5 By Test
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL LATERAL FLOW ASSAY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott
  • 11.2.2 Bio-Rad Laboratories Inc
  • 11.2.3 Siemens Healthineers AG
  • 11.2.4 BioMerieux
  • 11.2.5 BD
  • 11.2.6 Qiagen
  • 11.2.7 QuidelOrtho Corporation
  • 11.2.8 F. Hoffmann-La Roche
  • 11.2.9 DH Life Sciences LLC
  • 11.2.10 Quest Diagnostics
  • 11.2.11 Qiagen N.V